Abstract
Purpose
To describe the prevalence of the posterior pituitary bright spot (PPBS) in the general population on 1.5 and 3T MRI examinations and on 2D-T1 spin-echo (SE) and 3D-T1 gradient-echo (GE) sequences.
Materials and methods
1017 subjects who received an MRI of the brain for aspecific neurological complaints were included. MRI was performed on 1.5T in 64.5% and on 3T in 35.5% of subjects. Presence of the PPBS was evaluated on sagittal 2D T1-SE echo images with slice thickness 3 mm in 67.5% and on sagittal 3D T1-GE with slice thickness 0.9 mm in 32.5% of subjects.
Results
The PPBS was detectable in 95.9% of subjects. After correction for sex and age, no statistically significant difference could be seen concerning PPBS detection between 1.5 and 3T MRI examinations (p = 0.533), nor between 2D T1-SE and 3D T1-GE sequences (p = 0.217). There was a statistically significant association between increasing age and the absence of the PPBS (p < 0.001). The PPBS could not be identified in 6.2% of male subjects, compared to 2.2% of female subjects (p = 0.01).
Discussion
Absence of the PPBS can be seen in 4.1% of patients undergoing MRI of the brain for non-endocrinological reasons. Neither field-strength nor the use of a thick-sliced 2D T1-SE versus a thin-sliced 3D T1-GE sequence influenced the detectability of the PPBS. There is a statistically significant association between increasing age and male sex and the absence of the PPBS.
Similar content being viewed by others
Abbreviations
- 3D-MP RAGE:
-
3D-magnetization prepared rapid gradient-echo
- ADH:
-
Anti-diuretic hormone
- PPBS:
-
Posterior pituitary bright spot
- T1-SE:
-
T1-spin echo
References
Osborn AG (2013) Osborn’s brain, imaging, pathology, and anatomy. Amirsys Pub., Salt Lake City, pp 683–687
Mark LP et al (1991) High-intensity signals within the posterior pituitary fossa: a study with fat-suppression MR techniques. AJNR AM J Neuroradiol 12:529–532
Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J (2006) T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 26:93–113
Fujisawa I et al (1987) Posterior lobe of the pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr 11:221–225
Fujisawa I (2004) Magnetic resonance imaging of the hypothalamic-neurohypophyseal system. J Neuroendocrinol 16:297–302
Liu W, Wang L, Liu M, Li G (2016) Pituitary morphology and function in 43 children with central diabetes insipidus. Int J Endocrinol. https://doi.org/10.1155/2016/6365830
Colombo N et al (1987) Posterior pituitary gland: appearance on MR images in normal and pathologic states. Radiology 165(2):481–485
Brooks BS et al (1989) Frequency and variation of the posterior pituitary bright signal on MR images. AJNR Am J Neuroradiol 10(5):943–948
Yamamoto A et al (2013) Influence of age and sex on signal intensities of the posterior lobe of the pituitary gland on T1-weighted images from 3 T MRI. Jpn J Radiol 31(3):186–192
Terano T, Seya A, Tamura Y, Yoshida S, Hirayama T (1996) Characteristics of the pituitary gland in elderly subjects from magnetic resonance images: relationship to pituitary hormone secretion. Clin Endocrinol (Oxford) 45:273–279
Diabetes Data and Statistics (2017) Centers for Disease Control and Prevention Website. https://www.cdc.gov/diabetes/data/index.html. Accessed 05 June 2017
Perucca J, Bouby N, Valeix P, Bankir L (2007) Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. https://doi.org/10.1152/ajpregu.00500.2006
Crofton JT, Dustan H, Share L, Brooks DP (1986) Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets. J Endocrinol 108:191–199
Acknowledgements
The authors would like to thank Dr. M. Van Bockstal (Department of Anatomic Pathology, UZ Gent, Belgium) for her help with the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Martin Wiesmann has received grants from Stryker Neurovascular. Siemens Healthcare, personal fees from Stryker Neurovascular. Silkroad Medical. Siemens Healthcare. Bracco, and non-financial support from Codman Neurovascular. Covidien. Abbott. St. Jude Medical. Phenox. Penumbra. Microvention/Terumo. B. Braun. Bayer. Acandis. ab medica. The other authors have nothing to disclose.
Ethical approval
For this type of study formal consent is not required.
Informed consent
This is a retrospective imaging analysis and patients cannot be identified based on the data and images provided, so no informed consent was obtained.
Rights and permissions
About this article
Cite this article
Klyn, V., Dekeyzer, S., Van Eetvelde, R. et al. Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences. Pituitary 21, 379–383 (2018). https://doi.org/10.1007/s11102-018-0885-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-018-0885-3